Anti-melanoma differentiation-associated gene 5 (MDA5) antibodies were identified in 2005 in a subset of Japanese patients with amyopathic DM and rapidly progressive interstitial lung disease (RP-ILD) (2). This evidence concerns the gene IFIH1 and dermatomyositis.